User profiles for "author:Shahrukh Hashmi"

Shahrukh Hashmi

Mayo Clinic / SSMC
Verified email at mayo.edu
Cited by 10145

[HTML][HTML] The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis

GM ElGohary, S Hashmi, J Styczynski… - … /oncology and stem cell …, 2020 - Elsevier
Numerous studies have been published regarding outcomes of cancer patients infected with
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus causing the …

[HTML][HTML] Biology of premature ageing in survivors of cancer

MC Cupit-Link, JL Kirkland, KK Ness, GT Armstrong… - ESMO open, 2017 - Elsevier
Over 30 million cancer survivors exist worldwide. Survivors have an earlier onset and higher
incidence of chronic comorbidities, including endocrinopathies, cardiac dysfunction …

Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis

S Hashmi, M Ahmed, MH Murad, MR Litzow… - The Lancet …, 2016 - thelancet.com
Background Graft-versus-host disease (GVHD) is the major limitation of allogeneic
haemopoietic stem-cell transplantation (HSCT), for which no approved treatments are …

[HTML][HTML] Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

LTJ Hickson, LGPL Prata, SA Bobart, TK Evans… - …, 2019 - thelancet.com
Background Senescent cells, which can release factors that cause inflammation and
dysfunction, the senescence-associated secretory phenotype (SASP), accumulate with …

[HTML][HTML] Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study

JN Justice, AM Nambiar, T Tchkonia, NK LeBrasseur… - …, 2019 - thelancet.com
Background Cellular senescence is a key mechanism that drives age-related diseases, but
has yet to be targeted therapeutically in humans. Idiopathic pulmonary fibrosis (IPF) is a …

[HTML][HTML] Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease

R Zeiser, N Polverelli, R Ram, SK Hashmi… - … England Journal of …, 2021 - Mass Medical Soc
Background Chronic graft-versus-host disease (GVHD), a major complication of allogeneic
stem-cell transplantation, becomes glucocorticoid-refractory or glucocorticoid-dependent in …

[PDF][PDF] Lessons learned from large-scale, first-tier clinical exome sequencing in a highly consanguineous population

D Monies, M Abouelhoda, M Assoum… - The American Journal of …, 2019 - cell.com
We report the results of clinical exome sequencing (CES) on> 2,200 previously unpublished
Saudi families as a first-tier test. The predominance of autosomal-recessive causes allowed …

A rapid, accurate and machine-agnostic segmentation and quantification method for CT-based COVID-19 diagnosis

L Zhou, Z Li, J Zhou, H Li, Y Chen… - IEEE transactions on …, 2020 - ieeexplore.ieee.org
COVID-19 has caused a global pandemic and become the most urgent threat to the entire
world. Tremendous efforts and resources have been invested in developing diagnosis …

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

L Muffly, MC Pasquini, M Martens… - Blood, The Journal …, 2017 - ashpublications.org
In this study, we evaluated trends and outcomes of allogeneic hematopoietic cell
transplantation (HCT) in adults≥ 70 years with hematologic malignancies across the United …

[HTML][HTML] One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family …

D Niederwieser, H Baldomero, N Bazuaye… - …, 2022 - ncbi.nlm.nih.gov
Abstract The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the
mission of promoting hematopoietic cell transplantation (HCT) for instance by evaluating …